SEC Form D · Amendment · filed December 2, 2021
Cyrus Biotechnology, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Gus Tai · Seattle, WADirectorMark Benjamin · Seattle, WAExecYifan Song · Seattle, WAExec · DirectorLucas Nivon · Seattle, WAExec · DirectorChad Waite · Seattle, WADirectorGijs F. Van Thiel · New York, NYExec · DirectorRobert C. Green · Cambridge, MAExec · DirectorNicholas J. Esterline · WICHITA, KSExecJoshua F. Sobeck · New York, NYDirectorDavid Chao · Houston, TXDirectorPaul Martino · SAN FRANCISCO, CAExec · DirectorNicholas Manolelis · Los Angeles, CADirectorJeff Bicksler · Atlanta, GAExec · DirectorJames Kim · Alameda, CAExecBrandon Alexandroff · Longboat Key, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗